Cara at Home

One of our “recent” blogs had Cara coming home from hospital. Well as you can see she is well and truely home and almost one!!!! After a bit of shaky start she is now doing wonderfully.

The first three months of her life Cara did not want to be here. She was miserable, did not sleep and did not put on weight. There was nothing specifically wrong, just a prognosis of – “failure to thrive”. Not a pleasant phrase to see on your daughter’s medical charts. But once she learnt to smile, boy did she work it. She is now one of the smiliest, happy, energetic babies I have had a pleasure of seeing.

She is a pure JOY – so full of life. We are so grateful she is here.
While not taking away from Ellen, she has helped heal so many hurts that the death of Ellen brought us. She makes our family whole.

We are some of the lucky ones……
Thank you to everyone who shares our journey with us

Harry’s Birthday

Harry Turned Four Yesterday! I can’t believe how much he has grown. We celebrated his day with a small family party and a “H”cake. He was so happy, he sang and danced his way through the morning in his very cool Batman suit.

While we would be lying if we said that (as with all children), life with Harry has always been easy, yesterday was a wonderful day – a celebration of his life. Yesterday he was heaven sent and absolutely delightful.

He woke up singing he was so excited. Morning cuddles were followed by some present opening, and then some more cuddles for his beautiful sister who was now awake.

A great day was had by all of us. Who would have thought???????

Over the years quite a few people have posted comments asking about whether neonatal hemochromatosis NH is related to hereditary hemochromatosis.  This article by Peter Whitington explains hereditary hemochromatosis and how NH is different.

Cara’s now out of the special care nursery and, fingers crossed, will be home tomorrow. One or two outstanding tests could delay us by a day. We finally got a family snap. Someone though, wasn’t smiling for the camera until she was fed!

Cara’s graduated from intensive care back into special care. Everything looks like it’s progressing as it should, and we’re hopeful things are still on track to have her home soon.

We’re thrilled to announce the arrival of Cara Grace Jordan.

Born Tuesday 19 August at 10:38, weighing 3140g.
She is a much loved and anticipated addition to our family.

Unfortunately she’s still in the Neonatal Intensive Care Unit, and will be there for at least a few days as the doctors monitor her closely. Her serum ferritin levels were about 10x higher than Harry’s. However, most of the tests that have come back are positive, so we’re hopeful she’ll be ready to come home by the end of the week.

It’s been a very long time since we last posted here. And there’s been a lot happening! The biggest news is that Mary is pregnant again, now about 23 weeks, and everything is going fine. You can see more ultrasound images here.

It’s also been exciting to be in contact once again with Dr Whitington and hear of the more recent progress in the research. See my comments on his recent paper here.

Mary’s going through the treatment again, and it’s running quite a bit smoother compared to last time. Though it’s no walk in the park. While using Intragam makes the infusion go a lot quicker, there’s still a lot of headaches and needles and time spent in hospitals. Also interestingly, for other people with NH experience, Dr Whitington’s protocol has changed somewhat since Mary underwent the treatment with Harry. Instead of starting at 18 weeks, Mary commenced at 14 weeks, and then had the second treatment at 16 weeks, before the weekly treatments started at week 18. This is based on a theory that damage to the foetus could start earlier than previously thought.

Apologies for the long break between posts. We’ll update you on our progress in the not too distant future.

Dr Peter Whitington and Susan Kelly have just had their latest research published in Pediatrics.  I’ve summarised the key points from the abstract below, and if your lucky this link may take you to a pdf version of the complete article.

Whitington P & Kelly S, 2008, “Outcome of Pregnancies at Risk for Neonatal Hemochromatosis Is Improved by Treatment With High-Dose Intravenous Immunoglobulin”, Pediatrics published online May 12, 2008; DOI: 10.1542/peds.2007-3107

In summary the article builds upon his earlier work (see my posts here, here and here) .  The number of women involved in his study has increase to 48 (including Mary!) treated over 53 pregnancies.   The histories of the women demonstrated the high risk of occurrence of neonatal hemochromatosis: 92% of pregnancies ended badly, or in the papers words “resulted in intrauterine fetal demise, neonatal death, or liver failure necessitating transplant”.  “In contrast, with gestational therapy, the 53 at-risk gestations resulted in 3 failures and 52 infants who survived intact with medical therapy alone. When compared on a per-woman or per-infant basis, the outcome of gestation at risk for neonatal hemochromatosis was improved by gestational therapy.

The paper concludes that neonatal hemochromatosis seems to be the result of a gestational alloimmune disease, and occurrence of severe neonatal hemochromatosis in at-risk pregnancies can be significantly reduced by treatment with high-dose intravenous immunoglobulin during gestation.

We hear from people reasonably regularly who have lost children through NH.  We recently heard from about Alice Rowlands  who passed away after 5 days trying to fight the disease.  Miranda has set up a web site in memory of Alice.

It’s terrible and tragic and it reminds us how lucky we are to have Harry and how much we miss Ellen.

Finally got around to updating a few photos on the flickr site. This one was taken this morning as Harry and Mum set off on the 200m walk to Harry’s new day care – he loves it!

We shed a few tears this evening watching Australian Story (an Australian TV program). This week’s episode told the story of Jane and Andrew, a couple who lost a child at 8 months.

A couple of things really struck a chord with Mary and I. The way Andrew talked about “washing the crap away”. Another moment that rang true was Jane’s comment about how many people around her ignored the fact that her wonderful child had lived and died, even though she felt her child, Jackson, was and is always with her.

Jackson died on the day that Ellen was due, and their lovely son Sam, who is now two, was born 5 days before Harry. Some stories hit home harder than others.

You can watch the full episode (titled “War Story”) here.

An Italian team of doctors has now published a paper (abstract here) where they appear to have successfully used exchange transfusions to treat Neonatal Hemochromatosis (“NH”) in a new born. This potentially offers hope to parents who, without any prior warning, find out at birth that their child has NH.

The great progress that Dr Whitington and his team are making with their pregnant mother IVIg treatment has an obvious downside: you have to know there is a possibility the child about to be born will have NH. Anecdotally the odds are around 1 in 100,000. So, given the cost and huge commitment (read about Mary’s experience here), you’re not going to have this treatment unless there’s a good chance the baby will have NH. As it happens there is a good(?!) test – if you’ve previously had a baby with NH there’s an 80% chance that your future children will also suffer the disease. In practice, the tradgedy is that you’ve probably lost a child before the benefits of the IVIg treatment in future pregnancies are available.

We’ve blogged previously about antioxidant and iron chelation therapy (here), and up until now this therapy, along with liver transplantation, were the only treatments available to new borns suffering from NH.  Exchange transfustions involve removing red blood cells or platelets and replacing them with transfused blood product.  It is used as a treatment for other alloimmune diseases in new borns.  It will be interesting to see whether this becomes a more standard and accepted treatment for new borns who present with NH symptoms at birth.

Dr Peter Whitington, who developed the IVIg gestational treatment that Mary underwent, has published another paper.

Neonatal Hemochromatosis: A Congenital Alloimmune Hepatitis, Seminars on Liver Disease, 2007, Vol 27, pp 243-250.

I haven’t had the opportunity to review the paper yet, however the abstract states recent research has confirmed Dr Whitington’s alloimmune hypothesis.  Proof of this came through lab tests on mice which were able to reproduce the disease.  The title of the paper suggests that the disease should be renamed “congenital” (medical condition present at birth) “alloimmune” (see the wikipedia definition here) “hepatitis” (causing liver damage). Makes sense.

This research will hopefully one day help identify the antigen responsible for the alloimmune problems and lead to a simple and cheap treatment for the mothers of NH babies in subsequent pregnancies.  I look forward to providing a more thorough lay person review (I’ll have the medical dictionary handy) once I’ve got a full copy of the paper.

Harry turned 2 a couple of weeks ago, so it’s high time a couple of photos made it onto the internet of the occasion. He had a great time!


Could not resist posting this photo!

An eventful week or so for the family.  Pa and Grandma came over to celebrate Pa’s birthday (cake is a Harry favourite).  It was also Rebecca’s christening (Harry’s cousin) last week.

The photos above are posted using Picasa.  Thought I’d try the Google Picasa option to see how it works.  It’s easier to upload photos but I think Flickr has a better feel and can link with this blog better.  Anyway, enough of the techno details, you want more videos.

Harry’s very fond of the Wiggles. The problem is that Mum and Dad have had enough. The three Wiggles DVDs that we have have been watched to death. Mary’s good idea was to buy the Mary Poppin’s DVD for a change. Such decisions can have unintended consequences


Harry and Sam

Almost three months since the last post here on the blog and a lot’s happened. We’ve settled in nicely to our new home in Dutton Park and are really enjoying being so close to the city. It’s about a 2 minute bike ride down hill to Southbank where the bike tracks and play gyms have seen a fair bit of Harry. It’s also been great to catch up with some more friends – and for Harry to meet some new ones.


Two little boys

It was a great surprise to catch up with Bill, Linda and Lachlan on the weekend. It’s fantastic to watch two toddlers have a really good time together!

John, Debbie and Rebecca


Harry got his first cousin earlier this week (and Mary and I became aunty and uncle). Exciting stuff!!

There appears to have been quite a bit of coverage lately on a recent journal article by Grabhorn et al (actually it’s not so recent anymore – took a while for me to investigate it). The Birth and Breastfeeding News blog, an article distributed by Reuters Health, and an update on the neonatalhemochromatosis.org all report on the findings of the paper. The favourable outcomes the paper refers to are all about increased successful outcomes when infants are treated with an antioxidant-chelator therapy and/or receive liver transplantations. The antioxidant-chelator therapy is essentially a cocktail of drugs that help mop up the damaging excess iron and free radicals in the body of babies born with NH.

I’ve attempted to summarise the results from the study as clearly as possible below.

  • 4 infants received no treatment at all
    • 3 died within 25d, a good outcome for the other
  • 5 infants received antioxidant-chelator therapy only
    • 1 died at6 weeks, the other four had good outcomes
  • 5 infants received antioxidant-chelator therapy followed by liver transplantation
    • 1 died at 26 months, the other four had good outcomes
  • 2 infants received a liver transplantation
    • both infants had good outcomes

This all sounds really good, but you have to bear in mind a few things. In our experience the doctors were not alert to the possibility of NH as a diagnosis (you can’t really blame them, this is a rare disease). In fact Ellen’s diagnosis was only confirmed after an autopsy, so the chances of getting this treatment if no-one is expecting it are low. But for Harry we were alert to the high chance of recurrence. As you can see above the odds are still not great, but they do seem to improve with the antioxidant-chelator therapy.

Liver transplantation has long been known to be a successful way of treating babies with NH, but our advice from doctors was that you would have to be pretty lucky to get one in time.

When we became pregnant with Harry, news of the antioxidant-chelator therapy was the first bit of hope that we might have a healthy baby. I think one of the Doctors gave us a copy of a paper by Flynn et al.

However, like so many things associated with NH, it’s not all black and white. Leonis & Balistreri point out that there are agents within the antioxidant-chelator cocktail that may be potentially dangerous to newborns. They also refer to a paper by Rodrigues et al who studied 19 infants and found outcomes of the 10 infants who received antioxidant-chelator therapy were nearly identicle to the 9 that did not.

But then again… Flynn concluded that:

…Early treatment with antioxidant cocktail is beneficial and may be curative in those who present with milder phenotype [Note: this seems to have been what happened with Harry]. Liver transplantation should always be considered at an early stage in non-responders and in children with more severe acute liver failure.

So what does it all mean? I don’t really know (which is not surprising considering my completely non-extensive medical experience!). Like everything else it just means you need to ask lots of questions… and that there’s always something more behind the quick media releases (but you knew that already).

Finally, the treatment does not appear to have anywhere near the success associated with the IVIg treatment (that Mary had with Harry) which results in babies who present with a much milder form of NH. For the record, Harry received Vitamin E (an antioxidant), but not the complete chelator cocktail, after he was born as part of the standard treatment when his ferritin levels were found to be high.

I understand Dr Whitington will be publishing a new paper updating the progress of the IVIg treatment in the coming months, so I’ll report back then.

References

  1. Grabhorn, E., Richter, A., Burdelski, M., Rogiers, X., and Ganschow, R., 2006, “Neonatal Hemochromatosis: Long-term Experience With Favorable Outcome” PEDIATRICS, Vol. 118 No. 5 November 2006, pp. 2060-2065 (doi:10.1542/peds.2006-0908)
  2. Leonis, M & Balistreri, W, 2005, “Neonatal hemochromatosis: It’s OK to say ‘NO’ to antioxidant-chelator therapy”, Liver Transplantation, Vol 11, Issue 11, pp1323-1325 (doi:10.1002/lt.20541)
  3. Rodrigues F, Kallas M, Nash R, Cheeseman P, D’Antiga L, Rela M, Heaton N, Mieli-Vergani G, 2005, “Neonatal hemochromatosis-medical treatment vs. transplantation: the Kings experience” Liver Transplantation, Vol 11: pp1417-1424
  4. Flynn D, Mohan N, McKiernan P, Beath S, Buckels J, Mayer D, Kelly D, 2002, “Progress in treatment and outcome for children with neonatal haemochromatosis”, Archives of Disease in Childhood Fetal and Neonatal Edition, 88:F124

Next Page »